Aditxt, Inc. (NASDAQ:ADTX) Short Interest Down 38.3% in March

Aditxt, Inc. (NASDAQ:ADTX) was the target of a large decline in short interest during the month of March. As of March 13th, there was short interest totaling 44,231 shares, a decline of 38.3% from the February 26th total of 71,675 shares. Approximately 48.6% of the company’s stock are sold short. Based on an average daily volume of 167,388 shares, the short-interest ratio is currently 0.3 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aditxt presently has an average rating of “Sell”.

Aditxt Stock Down 8.0%

Shares of ADTX opened at $0.81 on Friday. The company has a market capitalization of $72,900.00, a price-to-earnings ratio of 0.00 and a beta of 1.53. Aditxt has a 52-week low of $0.80 and a 52-week high of $5,324.92. The stock has a 50 day moving average price of $4.47 and a 200 day moving average price of $162.78.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.